Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Continues to Urge CMS to Make Changes to Meaningful Use Incentive Program

Tuesday, May 08, 2012

In a formal comment letter, ASA urged the Centers for Medicare & Medicaid Services (CMS) to make changes to the Meaningful Use Stage 2 proposed rule. As written, the proposed rule still does not adequately address the modifications needed for anesthesiologists to participate in the incentive program.  Currently, a majority of anesthesiologists are deemed eligible for the incentive, but are unable to successfully satisfy the meaningful use criteria due to the nature of anesthesiology practices and the ways in which anesthesiologists use Electronic Health Record (EHR) systems.

ASA expressed concern that despite Congressional intent anesthesiologists are not deemed a hospital based eligible professional as defined by the regulations. ASA has continued to recommended criteria that would allow anesthesiologists to participate, or alternatively, that anesthesiologists be able to apply for a hardship exemption.

ASA has repeatedly advocated these concerns to CMS and the Office of the National Coordinator (ONC) on several occasions over the past several years and will continue to actively seek the necessary modifications for anesthesiologist participation.

Review ASA’s communication to the proposed rule on Meaningful Use Stage 2.
Review ASA's Anaylsis and Recommendations for Meaningful Use Requirements. 
Review background on EHRs.

« Back to Washington Alerts